Francesca Barone - 25 Jun 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Signature
/s/ Charles Schoch, as Attorney-In-Fact for Francesca Barone
Issuer symbol
CADL
Transactions as of
25 Jun 2025
Net transactions value
+$19,997
Form type
4
Filing time
26 Jun 2025, 08:30:05 UTC
Previous filing
20 Mar 2025
Next filing
28 Jan 2026

Sponsored

Quoteable Key Fact

"Francesca Barone filed Form 4 for Candel Therapeutics, Inc. (CADL) on 26 Jun 2025."

Quick Takeaways

  • This page summarizes Francesca Barone's Form 4 filing for Candel Therapeutics, Inc. (CADL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 26 Jun 2025, 08:30.

What Changed

  • Previous filing in this sequence was filed on 20 Mar 2025.
  • Current net transaction value: +$19,997.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Barone Francesca Chief Scientific Officer C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch, as Attorney-In-Fact for Francesca Barone 26 Jun 2025 0001909680

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Award $19,997 +4,282 +4.4% $4.67 100,809 25 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.